Nonprofit biomedical research institute for genomics and drug discovery
Broad Institute of MIT and Harvard is a Cambridge nonprofit running genomics, spatial biology and therapeutics research on a stack that pairs lab instruments (Illumina, 10x Genomics, LC-MS, HPLC) with computational tooling like GATK, gnomAD, Airflow and dual AWS/GCP clouds. Hiring is accelerating and overwhelmingly research-focused, centered on spatial multi-omics, multiple myeloma and early drug discovery work.
Founded in 2003, the Broad Institute of MIT and Harvard is a nonprofit biomedical research organization headquartered in Cambridge, MA, with 1,001–5,000 employees. It is organized into core member labs, programs and platforms that collaborate on human biology and disease. Research areas include genomics, genome sequencing and analysis, proteomics, metabolite profiling, chemical biology, imaging, cancer and therapeutics discovery. Operations run on enterprise systems such as Workday, SAP and Adaptive Planning, alongside Jira, Confluence and Smartsheet for coordination.
The Broad uses Python, Java, C++, Groovy and Jupyter for computation, GATK, gnomAD and ClinVar for genomics, Apache Airflow on AWS and GCP, plus Illumina, 10x Genomics and LC-MS lab platforms.
Yes. Hiring is accelerating and dominated by research roles across junior to principal levels, with smaller openings in engineering, finance and operations, all in the United States.
Active work includes new spatial and temporal genomics technologies, Slide-seq and Slide-tags studies of cancer and regeneration, spatial multi-omics in multiple myeloma, and early drug discovery projects.
Other companies in the same industry, closest in size
Broad Institute of MIT and Harvard's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.